Tenascin-C is a useful marker for disease activity in myocarditis - Wikidata - wikimedia - TriplyDB

Tenascin-C is a useful marker for disease activity in myocarditis

Tenascin-C is a useful marker for disease activity in myocarditis

http://www.wikidata.org/entity/Q28214545

about

sameAs

Can serum tenascin-C be used as a marker of inflammation in patients with dilated cardiomyopathy?The Inflammatory Heart Diseases: Causes, Symptoms, and Treatments.Tenascin-C induces inflammatory mediators and matrix degradation in osteoarthritic cartilage.Bioinformatics multivariate analysis determined a set of phase-specific biomarker candidates in a novel mouse model for viral myocarditis.Tenascin-C aggravates autoimmune myocarditis via dendritic cell activation and Th17 cell differentiation Advances in tenascin-C biology.Effect of postconditioning on dynamic expression of tenascin-C and left ventricular remodeling after myocardial ischemia and reperfusion.High tenascin-C levels cause inadequate myocardial blush grade in patients with acute myocardial infarction Matricellular proteins in cardiac adaptation and disease.The importance of cardiac biomarkers on remodelling after myocardial infarction cDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours.Involvement of large tenascin-C splice variants in breast cancer progression Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study Effluent Tenascin-C Levels Reflect Peritoneal Deterioration in Peritoneal Dialysis: MAJOR IN PD Study.Mechano-regulated tenascin-C orchestrates muscle repair.Type A dissection and chronic dilatation: tenascin-C as a key factor in destabilization of the aortic wall.Detection of Soluble ED-A(+) Fibronectin and Evaluation as Novel Serum Biomarker for Cardiac Tissue Remodeling.Comparative mRNA and MicroRNA Profiling during Acute Myocardial Infarction Induced by Coronary Occlusion and Ablation Radio-Frequency Currents.Histochemistry and cell biology: the annual review 2010.Matricellular proteins: new molecular targets to prevent heart failure.Molecular signatures and the study of gene expression profiles in inflammatory heart diseases.Tenascins and inflammation in disorders of the nervous system.Emerging biomarkers for heart failure: an update.Tenascin-C in cardiovascular remodeling: potential impact for diagnosis, prognosis estimation and targeted therapy.Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury.Extracellular matrix-mediated cellular communication in the heart.Tenascin-C enhances crosstalk signaling of integrin αvβ3/PDGFR-β complex by SRC recruitment promoting PDGF-induced proliferation and migration in smooth muscle cells.Co-stimulation of human breast cancer cells with transforming growth factor-beta and tenascin-C enhances matrix metalloproteinase-9 expression and cancer cell invasion.Tenascin C upregulates interleukin-6 expression in human cardiac myofibroblasts via toll-like receptor 4 Distribution of myofibroblast and tenascin-C in cystic adventitial disease: comparison with ganglion.Serum tenascin-C level is associated with coronary plaque rupture in patients with acute coronary syndrome.De novo expression of fetal ED-A(+) fibronectin and B (+) tenascin-C splicing variants in human cardiac allografts: potential impact for targeted therapy of rejection.Serum levels of large tenascin-C variants, matrix metalloproteinase-9, and tissue inhibitors of matrix metalloproteinases in concentric versus eccentric left ventricular hypertrophy.Tenascin-C levels in pseudosynovial fluid of loose hip prostheses.

P2860

Q30448431-CB708FFE-C385-4ECD-B637-8CE5B1E6614C Q30892742-2E4B89EA-7D1B-4D23-BF2B-BC3425F41C76 Q33962572-A435F70C-5C84-4A89-B413-CF9EA96F2829 Q35096144-03C0FA7A-FE2F-491B-8CD4-BADFD3F1782E Q35114877-8EA9CF11-EA3F-4C6C-92F1-37A5BFEFA926 Q35214557-AA90A47C-1C67-465F-8BBA-1B5524E2A26D Q35365832-DC605C0E-F250-4DA1-8D1E-B7F0BC249A0C Q35480748-30CE3B6E-AA26-44BF-83AD-8AA539871902 Q35542423-D0635021-273B-4419-A791-E9236E0D36B0 Q35757014-47BFD76A-CD94-4FD1-996F-C448FC9A3D58 Q35769723-5B353461-DB90-4516-9463-D4F393604E86 Q35791432-FC4A9E1E-94FE-4322-BC6C-6FCF58C13631 Q36321563-EBF0643F-FFD0-4DA2-802B-E2836A19F693 Q36386616-AFE532B4-0A71-441D-8E38-C34C6BB2AF47 Q36870043-9C1B9C12-B29E-4AB3-944F-15CE9B011AB3 Q37024218-DB772870-8EBD-4FD6-90F4-00A63F90E404 Q37222913-E23F6BAA-EC5B-4519-8BDD-B84ABBD09E07 Q37441111-092553A8-B6D7-4631-AFF9-F910656F66E9 Q37833524-D2FE998B-98C4-44B7-B1C5-2E375207FBD8 Q37925022-337F2DD2-73AD-4C23-AB86-9B958781134E Q38037357-460D52D4-35F1-4869-B00A-24CB87AD692E Q38069948-79C5BF76-23D8-4167-AD5A-8561653F9FC6 Q38249995-F900661E-A32A-477F-ABA9-47C5E3BB4690 Q38308741-0765EFE6-B126-419A-8E0B-BCDAE20623D6 Q38594699-1BC878D6-AF1B-46CF-A564-005AD5141AF3 Q38632188-5AD27554-19C9-4C57-A1E9-B164A4F0D37B Q39500221-7E830098-0AB7-4FA4-8C44-A397431C0EF9 Q40487608-60B96A23-05C0-4B9F-9DD7-A39CA29279BC Q42767722-367D3BFB-F23E-4933-ADE1-C954A94824D0 Q43941861-E68020C4-ACA5-4A9A-A00E-34596EC8A0E4 Q44375221-87752359-8ACA-4314-99A2-C63215CBDBDF Q45225869-D82E5326-3A22-4194-8AFA-1A0D25DE730A Q45797489-953D0BDD-0892-4259-A092-262D4199B2E6 Q51293564-18288563-66EA-40AC-BC68-79B05A3DFF01

P2860

Tenascin-C is a useful marker for disease activity in myocarditis

http://www.wikidata.org/entity/Q28214545

description

2002 nî lūn-bûn

@nan

2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Tenascin-C is a useful marker for disease activity in myocarditis

@ast

Tenascin-C is a useful marker for disease activity in myocarditis

@en

Tenascin-C is a useful marker for disease activity in myocarditis

@nl

type

label

Tenascin-C is a useful marker for disease activity in myocarditis

@ast

Tenascin-C is a useful marker for disease activity in myocarditis

@en

Tenascin-C is a useful marker for disease activity in myocarditis

@nl

prefLabel

Tenascin-C is a useful marker for disease activity in myocarditis

@ast

Tenascin-C is a useful marker for disease activity in myocarditis

@en

Tenascin-C is a useful marker for disease activity in myocarditis

@nl

P1433

Q28214545-D42C6B09-276E-46F3-B16D-48A296AF1BF1

P1476

Q28214545-ACAA1C02-958C-48B6-B802-D28CF9B6746D

P2093

Q28214545-0AEAAC95-00BC-4786-9B23-FC3404A8DA68

Q28214545-1B385BB2-F216-446F-A3C2-8A0D0883DB59

Q28214545-46DF3BED-2348-4ACF-A5B4-B535A44EFC39

Q28214545-8A4334D9-0931-4946-9C1A-BFFDD262BB1A

Q28214545-B4D28A2F-104A-475B-8FCE-38151DC9FE66

Q28214545-C49506D9-3509-4D18-971F-F55B4FC5A428

Q28214545-D90D35B1-4E88-4644-9B45-F9D958B37271

Q28214545-DC06E754-71B3-478B-9CAB-A240A5036419

Q28214545-E0955949-2DD3-4DB7-BBC3-C491D578BA6C

P2860

Q28214545-044BFDA3-E1A9-40A9-9B21-837AC92CA561

Q28214545-08BE1599-2ED5-488C-89D8-AAAD949F14D9

Q28214545-19D8AFBA-5BC7-4EAD-8328-75E6DCAD9339

Q28214545-1CA95AC3-2DD4-4B5F-924C-37B2325FDB8D

Q28214545-25DC8393-381C-455D-957F-3E331F75127B

Q28214545-293105BA-72A0-4D0E-BF2F-FD5AFE2A0A6D

Q28214545-360DE8C3-EED1-4A0B-9EEC-905A5C740E00

Q28214545-56DA8E43-0BFB-4480-A03C-88D83F1F0467

Q28214545-592B2032-4A79-4703-95A7-14AD4DDB7AA9

Q28214545-893D1CB6-2207-4E9B-B3A2-545F6BFBC63E

P304

Q28214545-379017B7-628B-4F8A-AE30-91C2FE38FCAD

P31

Q28214545-BCF0BE11-A903-406B-ACEC-D0C682F8A997

P3181

Q28214545-38DDEFF4-DC5B-40F1-871A-9DB008CC96ED

P356

Q28214545-6B008591-A6D4-489F-B0AC-C23D89E3F0AA

P407

Q28214545-21ACB350-5D33-489D-BEA1-FD8A2B69DAA7

P433

Q28214545-00F8D158-AE41-4421-90FE-F60B71D34290

P478

Q28214545-3A92AB61-EE98-4137-A078-D7043DDC1AC0

P50

Q28214545-5CA3D47B-DDFA-4AB7-8B88-64847162A0F4

P577

Q28214545-CC297886-F6CA-4D27-9D2E-3B13F2F50865

P698

Q28214545-E205E925-CABE-4FDB-AA44-FD7201C53C4F

P3181

P356

P1433

The Journal of Pathology

P1476

Tenascin-C is a useful marker for disease activity in myocarditis

@en

P2093

Kyoko Imanaka-Yoshida

http://www.w3.org/2001/XMLSchema#string

Michiaki Hiroe

http://www.w3.org/2001/XMLSchema#string

Naomi Noda

http://www.w3.org/2001/XMLSchema#string

Takuro Tsuchiya

http://www.w3.org/2001/XMLSchema#string

Teruyo Sakakura

http://www.w3.org/2001/XMLSchema#string

Tetsuya Toyozaki

http://www.w3.org/2001/XMLSchema#string

Toshiki Maki

http://www.w3.org/2001/XMLSchema#string

Toshio Nishikawa

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Yasutomi

http://www.w3.org/2001/XMLSchema#string

P2860

Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions

Expression of tenascin-C and the integrin alpha 9 subunit in regeneration of rat nasal mucosa after chemical injury: involvement in migration and proliferation of epithelial cells

Animal models for muscular dystrophy show different patterns of sarcolemmal disruption.

Tenascin expression in endomyocardial biopsy specimens in patients with dilated cardiomyopathy: distribution along margin of fibrotic lesions

Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy.

The challenge of cardiomyopathy.

The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients.

Autoimmune myocarditis.

Molecular and immune mechanisms in the pathogenesis of cardiomyopathy--role of viruses, cytokines, and nitric oxide.

Tenascin-C modulates adhesion of cardiomyocytes to extracellular matrix during tissue remodeling after myocardial infarction.

P304

388-394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4010480

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/PATH.1131

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

197

http://www.w3.org/2001/XMLSchema#string

P50

Toshimichi Yoshida

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12115886

http://www.w3.org/2001/XMLSchema#string